Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Retatrutide for Sale > Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder
Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - large image1
Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image1
Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image2
Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image3
Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image4
Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image5
Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image6

Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder

6837 Inquiries

Unit Price:

$40-50/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

zhongma

Packaging:

5mg/10mg/15mg/20mg*10vials

Price valid (until):

2027-09-30

Company Type:
Trader
Location:
China
Qualification:
Main Products:

GLP-1,Retatrutide,Tirzepatide,Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:Yara
    WhatsApp:+86 188 3099 2172
    Email:Yara@hzzmtrade.cn 


    ltems Specifications
    Product Name Retatrutide
    Appearance White freeze-dried powder
    Specification 5mg 10mg 15mg 20mg 30mg
    Purity >99%



    Details



     

    Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 1 Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 2 Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 3                                       Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 4


    These products are APIs (active pharmaceutical ingredients), not finished pharmaceutical products.

    They are intended solely for research and laboratory use.

    Buyers must fully comply with all applicable laws and regulations regarding the handling and use of this material.



    Advantages


    Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 5

    1. Ultra-High Purity

    Each batch is synthesized and purified to >99% purity (HPLC), ensuring reliable and reproducible results in sensitive experiments.


    2. Accurate Dosage and Consistency

    Our peptides are precisely weighed and vacuum-sealed under sterile conditions. Consistency between batches is strictly maintained.


    3. Endotoxin-Free and Sterile Processing

    Our peptides are manufactured in a cleanroom environment and are free of endotoxins, microbial contamination, and other impurities that may interfere with cell-based or in vivo studies.



    Manufacturing  


    Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 6

    1. Peptide Synthesis Expertise


    Extensive Experience: 7 years of experience in peptide synthesis and development.


    Technical Team: Experts in solid-phase and liquid-phase synthesis.


    2. Advanced Manufacturing Capabilities


    State-of-the-Art Facilities: High-precision equipment ensures purity and bioactivity.


    Scalable Production: From milligram-scale research peptides to industrial batches of several kilograms.


    3. Innovation and Commitment to Customers


    Reliable Supply Chain: Competitive pricing and timely global delivery.


    Global Reach: Trusted by researchers, pharmaceutical companies, and industrial customers worldwide.



      Global Services


    Who We Serve

    Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 7

    - We are proud to work with clients in North America, Europe, Asia, and Latin America, including:

    - Biotechnology and pharmaceutical companies

    - Research institutions and universities

    - Peptide formulation startups


      Product Delivery


    Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 8


    Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 9


    Shop Retatrutide | US Warehouse GLP-1 GIP GCG Peptides | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 10


       About Us


    Hangzhou Zhongma specializes in the development and global distribution of high-quality raw materials for research use only (RUO), including peptides, small molecules, and biochemical reagents.


    Our products are widely used in life science research, drug discovery, cosmetics, anti-aging medicine, and the functional health industry.


    1. Exceptional Product Quality


    Product quality is the cornerstone of our business. Peptides are synthesized via solid-phase peptide synthesis (SPPS), then purified by high-performance liquid chromatography (HPLC) and identified by mass spectrometry (MS).


    Each batch includes a Certificate of Analysis (COA), with key data including:

    • Purity (HPLC)

    • Molecular weight (MS)

    • Moisture content

    • Residual solvents

    • Microbial limits (if applicable)


    For customers with more stringent regulatory requirements, we can also provide third-party testing reports, endotoxin (LAL) data, and stability studies upon request.


    2. Customization and R&D Support


    We offer flexible custom synthesis services supported by an experienced R&D team. Whether you are seeking novel peptide sequences, cosmetic-grade purity, or modified molecules (such as cyclization or acetylation), we deliver high-quality results on time.


    Our services include:

    • Custom peptide synthesis (milligram to kilogram scale)

    • Peptide modification and labeling

    • Small molecule synthesis

    • Project-based research and scale-up


    We work closely with our clients to ensure technical feasibility, rapid delivery, and cost control throughout the development cycle.


    3. Extensive Product Portfolio


    We offer a comprehensive and continuously expanding product line:

    • Peptides: GLP-1 analogs (e.g., semaglutide, tezerapetide, retatide), cosmetic peptides (e.g., acetyl hexapeptide-8, Matrixyl), anti-aging peptides, and research peptides.

    • Small Molecules: Cognitive enhancers, NAD+ boosters (e.g., NMN, NR, NADH), and intermediates.

    • Biochemicals: Amino acid derivatives, enzyme cofactors, and custom reagents.


    New products are introduced regularly to meet evolving market demands. We also support bulk pre-orders for customers with ongoing or seasonal needs.


    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Other Chemical Drugs

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Retatrutide,Tirzepatide,Peptides

    Location:

    Room A008, 704#, Building 11, Shiliu Street Block, Liangzhu Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    6837 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.